Home / Netherlands / Aperam S.A.
Aperam S.A.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
711 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 30, 2013 | Adage Capital Management L.P. | 3.11% | still open |
| January 29, 2013 | Adage Capital Management L.P. | 3.08% | still open |
| January 25, 2013 | UBS O'Connor Limited | 0.48% | still open |
| January 22, 2013 | Adage Capital Management L.P. | 2.70% | still open |
| January 21, 2013 | Adage Capital Management L.P. | 2.25% | still open |
| January 21, 2013 | UBS O'Connor Limited | 0.52% | still open |
| January 17, 2013 | Adage Capital Management L.P. | 2.12% | still open |
| January 8, 2013 | Bocage Capital, LLC | 0.44% | still open |
| December 5, 2012 | Bocage Capital, LLC | 0.70% | still open |
| November 19, 2012 | TT International | 0.47% | still open |
| November 1, 2012 | TT International | 0.52% | still open |
Other companies sold short in the Netherlands
- Signify N.V. 10.57% of the capital sold short
- Akzo Nobel N.V. 8.44% of the capital sold short
- Pharming Group N.V. 8.11% of the capital sold short
- The Magnum Ice Cream Company N.V. 6.43% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 3.07% of the capital sold short
- Alfen N.V. 2.27% of the capital sold short
- Shell plc 2.05% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Aperam S.A., source AFM, data as at March 11, 2026, https://www.quivad.com/action/aperam-s-a?page=15